Columvi (Glofitamab)

Complete patient guide for uses, dosage, side effects, and safety information

Prescription Required

Quick Facts

Generic Name
glofitamab
Drug Class
Monoclonal Antibody
Used For
Treatment of diffuse large B-cell lymphoma (DLBCL) in adults
How Taken
Intravenous infusion, administered in cycles

What Is Columvi Used For?

Columvi is a medication that contains the active ingredient glofitamab, specifically designed for adults suffering from diffuse large B-cell lymphoma (DLBCL). It can be used alone or in combination with chemotherapy.

Primary Uses

Columvi is used to treat adults with DLBCL that has either relapsed or not responded to previous treatments, particularly when a stem cell transplant is not an option.

How It Works

Columvi binds to cancerous B cells and activates T cells, leading to the destruction of these cancer cells.

Good to know: Columvi is not addictive.

Continue Reading

Sign in to access the complete medication guide including dosage, side effects, warnings, and more.

How to Take Columvi

Columvi is administered under the supervision of a healthcare professional in a hospital or clinic setting.

Dosage Instructions

Columvi is given via intravenous infusion in cycles lasting 21 days, with up to 12 cycles possible. The treatment begins with a lower dose that is gradually increased.

What If You Miss a Dose?

If you miss a scheduled dose, contact your healthcare provider to reschedule as it is important not to miss doses for effective treatment.

Important: Never double up on doses if you miss one.

Available Tablet Strengths

2.5mg
2.5mg Tablet Clear, Vial • AUST R 389650
10mg
10mg Tablet Clear, Vial • AUST R 392331

Side Effects

Like all medications, this medicine can cause side effects. Most are mild and temporary, but some require medical attention.

Common Side Effects

These side effects occur relatively frequently and usually don’t require emergency care:

  • Reduced levels of lymphocytes, red blood cells, and platelets
  • Constipation
  • Nausea
  • Vomiting
  • Abdominal pain
  • Rash
  • Fatigue

Seek immediate medical attention if you experience:

  • Cytokine release syndrome: fever, fast heartbeat, dizziness, chills, shortness of breath
  • Neurologic toxicity including ICANS: confusion, disorientation, sleepiness
  • Tumor flare: swollen lymph nodes, chest pain, breathing difficulties
  • Tumor lysis syndrome: weakness, irregular heartbeat, confusion
  • Severe infections: fever, chills, difficulty breathing

Important Warnings

There are significant safety warnings associated with Columvi that patients should be aware of.

Who Should Not Take Columvi

Do not take Columvi if you have had an allergic reaction to glofitamab or any of its ingredients, or if you have an active infection.

Medical Conditions to Discuss

Inform your doctor if you have other medical conditions, take other medications, or are pregnant, planning to become pregnant, or breastfeeding.

Pregnancy and Breastfeeding

Columvi should not be used during pregnancy as it may harm the unborn baby. Effective contraception is advised during treatment and for 2 months after the last dose. Breastfeeding is not recommended while on Columvi.

Elderly Patients With Dementia: Special caution is advised for elderly patients, particularly those with dementia.

Drug Interactions

Certain medications may interact with Columvi, affecting its efficacy.

Alcohol & Driving

Be cautious with alcohol consumption and driving while on Columvi.

Alcohol

Consult your doctor regarding alcohol use while on Columvi.

Driving and Operating Machinery

Avoid driving or operating machinery if you experience symptoms of cytokine release syndrome or neurologic toxicity.

Storage

Columvi will be stored by your healthcare provider at the hospital or clinic.

Overdose Information

Overdose is unlikely as Columvi is administered under medical supervision. If you suspect an overdose, inform your healthcare provider immediately.

Frequently Asked Questions

The effects of Columvi may vary, and it is important to follow your doctor's guidance regarding treatment duration.

There are no specific instructions regarding food interactions with Columvi, but consult your doctor for personalized advice.

Columvi is not considered addictive.

Do not stop taking Columvi without consulting your doctor, as it may worsen your condition.

Consult your healthcare provider regarding alcohol consumption while on Columvi.

Weight gain is not specifically mentioned as a side effect of Columvi.

Elderly patients should use Columvi with caution, especially those with dementia.

Important Disclaimer

This information is intended for general educational purposes only and should not be considered medical advice. Always consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.

If you think you may have a medical emergency, call your doctor or emergency services immediately.

Create a free account to access the full medication guide.

Sign in to access your medication guides.